Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RISHI PAUL SINGH

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1750447660
CMS profile
306129
Location
BOSTON, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$455,984.01

226 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 5; records 101–150 of 226 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RISHI PAUL SINGH

NPI 1750447660 · CMS profile ID 306129

Allopathic & Osteopathic Physicians / Ophthalmology

BOSTON, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 226 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1750447660?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RISHI PAUL SINGH, NPI 1750447660, CMS profile ID 306129. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 226 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1750447660?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). RISHI PAUL SINGH, NPI 1750447660, CMS profile ID 306129. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 226 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1750447660?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
RISHI PAUL SINGH, NPI 1750447660, CMS profile ID 306129, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 226 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1750447660?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

226 matching records · $455,984.01 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 226 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 226.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Regeneron Pharmaceuticals, Inc. $1,080.0007/21/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000036215 CMS
Alcon Vision LLC $1,184.3107/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001585203 CMS
Apellis Pharmaceuticals, Inc. $26.6707/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056332941 CMS
Kyowa Kirin, Inc. $3,375.0007/11/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1027020057 CMS
Bausch & Lomb Americas Inc. $122.9507/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1037847963 CMS
Coherus Biosciences Inc. $4,846.5007/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060236783 CMS
Coherus Biosciences Inc. $834.3207/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060236793 CMS
EyePoint Pharmaceuticals US, Inc. $6,300.0007/01/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017492211 CMS
Coherus Biosciences Inc. $11,847.0006/13/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060236767 CMS
Coherus Biosciences Inc. $1,120.0706/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060236769 CMS
Apellis Pharmaceuticals, Inc. $15,264.0006/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056314555 CMS
Apellis Pharmaceuticals, Inc. $57.5306/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056366015 CMS
Apellis Pharmaceuticals, Inc. $1,086.0006/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056371389 CMS
Apellis Pharmaceuticals, Inc. $26.5006/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056378391 CMS
Alimera Sciences, Inc. $105.4906/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993543119 CMS
Apellis Pharmaceuticals, Inc. $58.8606/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056337327 CMS
Coherus Biosciences Inc. $2,423.2506/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060236765 CMS
Regeneron Healthcare Solutions, Inc. $2,116.0005/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999448413 CMS
Apellis Pharmaceuticals, Inc. $59.4305/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056325649 CMS
Apellis Pharmaceuticals, Inc. $1,086.0005/19/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056378963 CMS
Regeneron Healthcare Solutions, Inc. $529.0005/19/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999448395 CMS
Regeneron Healthcare Solutions, Inc. $2,645.0005/19/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999448401 CMS
Regeneron Healthcare Solutions, Inc. $3,174.0005/19/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999448407 CMS
Apellis Pharmaceuticals, Inc. $11,403.0005/17/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056346361 CMS
Apellis Pharmaceuticals, Inc. $192.7305/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056351209 CMS
Genentech USA, Inc. $112.9405/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040522459 CMS
Genentech USA, Inc. $6,720.0005/16/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040522467 CMS
Genentech USA, Inc. $809.5605/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040522475 CMS
Genentech USA, Inc. $136.3305/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040522483 CMS
Apellis Pharmaceuticals, Inc. $203.6505/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056335661 CMS
Apellis Pharmaceuticals, Inc. $490.8205/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056354093 CMS
Apellis Pharmaceuticals, Inc. $308.9705/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056310169 CMS
Apellis Pharmaceuticals, Inc. $641.0605/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056318767 CMS
Apellis Pharmaceuticals, Inc. $262.9705/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056371391 CMS
Apellis Pharmaceuticals, Inc. $180.0005/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056372208 CMS
Apellis Pharmaceuticals, Inc. $124.9905/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056378393 CMS
Coherus Biosciences Inc. $124.9705/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060236775 CMS
Apellis Pharmaceuticals, Inc. $582.2005/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056312993 CMS
Apellis Pharmaceuticals, Inc. $125.1605/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056334329 CMS
Apellis Pharmaceuticals, Inc. $275.4505/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056347547 CMS
Apellis Pharmaceuticals, Inc. $11,403.0005/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056348807 CMS
Apellis Pharmaceuticals, Inc. $12.0005/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056373501 CMS
Apellis Pharmaceuticals, Inc. $574.9705/04/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056332929 CMS
Apellis Pharmaceuticals, Inc. $122.6105/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056356525 CMS
Apellis Pharmaceuticals, Inc. $683.2005/04/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056378967 CMS
Carl Zeiss Meditec, Inc. $650.0005/04/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059458819 CMS
Hoffmann-La Roche Limited $2,940.0004/27/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040522669 CMS
Hoffmann-La Roche Limited $183.4404/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040522680 CMS
Hoffmann-La Roche Limited $110.0604/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040522687 CMS
Hoffmann-La Roche Limited $440.2504/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040522693 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $232,303.40 147
PY2020 $118,015.64 73
PY2021 $191,267.29 114
PY2022 $242,280.30 175
PY2023 $455,984.01 226
PY2024 $248,635.59 170
PY2025 $201,187.32 115

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $25,074.10 33
PY2024 Recipient $86,441.39 39
PY2024 Principal investigator $77,458.00 2
PY2023 Recipient $15,573.65 17
PY2022 Recipient $10,832.58 15
PY2022 Principal investigator $87,858.20 4
PY2021 Recipient $32,639.67 19
PY2021 Principal investigator $144,278.00 12
PY2020 Recipient $14,663.11 4
PY2020 Principal investigator $76,413.70 14
PY2019 Recipient $13,558.83 9
PY2019 Principal investigator $401,061.87 20

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

33 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Regeneron Pharmaceuticals, Inc. $339.68 09/13/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122784
Recipient Regeneron Pharmaceuticals, Inc. $339.68 09/12/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122780
Recipient Regeneron Pharmaceuticals, Inc. $373.65 09/12/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122782
Recipient F. Hoffmann-La Roche AG $778.13 08/29/2025 Covered Recipient Physician 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema: The FARETINA-DME Study No dispute reported 06/30/2026 1211538519
Recipient F. Hoffmann-La Roche AG $778.13 08/29/2025 Covered Recipient Physician 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Neovascular Age-Related Macular Degeneration: FARETINA-AMD No dispute reported 06/30/2026 1211538523
Recipient Regeneron Pharmaceuticals, Inc. $340.75 07/31/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122778
Recipient Regeneron Pharmaceuticals, Inc. $340.75 07/29/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122772
Recipient Regeneron Pharmaceuticals, Inc. $340.75 07/29/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122774
Recipient Regeneron Pharmaceuticals, Inc. $340.75 07/29/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122776
Recipient Regeneron Pharmaceuticals, Inc. $3,179.07 07/02/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122770
Recipient F. Hoffmann-La Roche AG $1,199.63 05/06/2025 Covered Recipient Physician Two-year real-world clinical outcomes in patients with neovascular age-related macular degeneration treated with faricimab in the US: The FARETINA-nAMD study No dispute reported 06/30/2026 1211538527
Recipient Regeneron Pharmaceuticals, Inc. $711.26 05/06/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122766
Recipient Regeneron Pharmaceuticals, Inc. $711.26 05/06/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122768
Recipient F. Hoffmann-La Roche AG $1,863.75 05/05/2025 Covered Recipient Physician Two-year real-world clinical outcomes in patients with diabetic macular edema treated with faricimab in the US: The FARETINA-DME study No dispute reported 06/30/2026 1211538532
Recipient Regeneron Pharmaceuticals, Inc. $711.26 05/05/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122762
Recipient Regeneron Pharmaceuticals, Inc. $711.26 05/05/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122764
Recipient Regeneron Pharmaceuticals, Inc. $52.89 05/02/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122756
Recipient Regeneron Pharmaceuticals, Inc. $48.96 05/02/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122758
Recipient Regeneron Pharmaceuticals, Inc. $53.86 05/02/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122760
Recipient Regeneron Pharmaceuticals, Inc. $5,492.60 04/26/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122754
Recipient Regeneron Pharmaceuticals, Inc. $44.88 04/16/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122745
Recipient Regeneron Pharmaceuticals, Inc. $44.88 04/16/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122747
Recipient Regeneron Pharmaceuticals, Inc. $44.88 04/16/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122750
Recipient Regeneron Pharmaceuticals, Inc. $44.88 04/16/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122752
Recipient F. Hoffmann-La Roche AG $778.13 03/31/2025 Covered Recipient Physician 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema: The FARETINA-DME Study No dispute reported 06/30/2026 1211538537
Recipient F. Hoffmann-La Roche AG $1,370.25 03/31/2025 Covered Recipient Physician Real-World Clinical Outcomes Update in Patients With Neovascular Age-Related Macular Degeneration in the US: The FARETINA-AMD Study No dispute reported 06/30/2026 1211538543
Recipient F. Hoffmann-La Roche AG $1,205.75 03/31/2025 Covered Recipient Physician 2-Year Real-World Clinical and Anatomical Outcomes in Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) Treated With Faricimab in the United States: The FARETINA Study No dispute reported 06/30/2026 1211538547
Recipient F. Hoffmann-La Roche AG $1,370.25 03/31/2025 Covered Recipient Physician Real-World Clinical Outcomes Update in Patients With Diabetic Macular Edema Treated With Faricimab in the US: The FARETINA-DME Study No dispute reported 06/30/2026 1211538552
Recipient F. Hoffmann-La Roche AG $778.13 03/31/2025 Covered Recipient Physician 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Neovascular Age-Related Macular Degeneration: FARETINA-AMD No dispute reported 06/30/2026 1211538556
Recipient Regeneron Pharmaceuticals, Inc. $171.00 01/14/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122737
Recipient Regeneron Pharmaceuticals, Inc. $171.00 01/14/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122739
Recipient Regeneron Pharmaceuticals, Inc. $171.00 01/14/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122741
Recipient Regeneron Pharmaceuticals, Inc. $171.00 01/14/2025 Covered Recipient Physician EYLEA CLINICAL DEVELOPMENT PROGRAM No dispute reported 06/30/2026 1184122743